ZFP184 inhibitors are a class of compounds specifically designed to target zinc finger protein 184 (ZFP184), a transcription factor involved in regulating gene expression by binding to specific DNA sequences. Like other zinc finger proteins, ZFP184 contains zinc finger motifs, which are essential structural domains that allow the protein to interact with DNA at defined regulatory sites. These zinc finger motifs are stabilized by zinc ions, which are critical for maintaining the protein's three-dimensional structure. This structure is vital for ZFP184's ability to recognize and bind to target DNA sequences, thereby controlling the transcription of various genes. Inhibitors of ZFP184 function by disrupting its DNA-binding activity, either by interfering with the zinc finger motifs or preventing the protein from interacting with its target DNA regions, leading to altered gene regulation and cellular responses.
The mechanisms by which ZFP184 inhibitors operate can vary depending on their chemical composition. One common mechanism involves chelating the zinc ions required for the stability of the zinc finger domains. By binding to these zinc ions, the inhibitors cause the structural integrity of the zinc finger motifs to collapse, rendering ZFP184 incapable of effectively binding DNA. Without this ability, ZFP184 loses its role in regulating the transcription of specific genes, which can significantly affect the cellular pathways it governs. Another potential mechanism involves inhibitors blocking interactions between ZFP184 and other proteins or cofactors necessary for its transcriptional regulatory function. By preventing these interactions, the inhibitors further impair the ability of ZFP184 to form necessary transcriptional complexes. Research into ZFP184 inhibitors provides valuable insights into the role of zinc finger proteins in gene expression, highlighting their importance in the broader context of cellular regulation and genetic control.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $73.00 $238.00 $717.00 $2522.00 $21420.00 | 53 | |
Actinomycin D inhibits RNA synthesis by intercalating into DNA, preventing transcription, and thus may inhibit the expression of ZNF184. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $40.00 $82.00 $256.00 | 127 | |
Cycloheximide inhibits protein synthesis by interfering with translocation during translation, potentially leading to reduced expression of ZNF184. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $36.00 $68.00 $107.00 $214.00 $234.00 $862.00 $1968.00 | 47 | |
Curcumin has been shown to modulate various transcription factors and inhibit gene expression, suggesting it could impact the expression of ZNF184. | ||||||
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | $32.00 $170.00 $385.00 | 63 | |
Etoposide inhibits topoisomerase II, leading to DNA damage and potential interference with ZNF184 expression. | ||||||
Flavopiridol | 146426-40-6 | sc-202157 sc-202157A | 5 mg 25 mg | $78.00 $254.00 | 41 | |
Flavopiridol is a cyclin-dependent kinase inhibitor that can suppress transcription by inhibiting RNA polymerase II, potentially affecting ZNF184 expression. | ||||||
2′-Deoxy-2′,2′-difluorocytidine | 95058-81-4 | sc-275523 sc-275523A | 1 g 5 g | $56.00 $128.00 | ||
Gemcitabine, a nucleoside analog, can inhibit DNA synthesis and potentially affect the expression of ZNF184. | ||||||
Hydroxyurea | 127-07-1 | sc-29061 sc-29061A | 5 g 25 g | $76.00 $255.00 | 18 | |
Hydroxyurea inhibits ribonucleotide reductase, leading to reduced DNA synthesis and potentially impacting ZNF184 expression. | ||||||
Mitomycin C | 50-07-7 | sc-3514A sc-3514 sc-3514B | 2 mg 5 mg 10 mg | $65.00 $99.00 $140.00 | 85 | |
Mitomycin C crosslinks DNA, forming adducts that inhibit DNA synthesis and potentially hinder the expression of ZNF184. | ||||||
Puromycin | 53-79-2 | sc-205821 sc-205821A | 10 mg 25 mg | $163.00 $316.00 | 436 | |
Puromycin is an aminonucleoside antibiotic that can terminate protein synthesis prematurely, potentially impacting the expression of ZNF184. | ||||||
Streptonigrin | 3930-19-6 | sc-500892 sc-500892A | 1 mg 5 mg | $102.00 $357.00 | 1 | |
Streptonigrin is a DNA-binding antibiotic that can cause DNA damage, potentially interfering with the expression of ZNF184. | ||||||